Compare PPG & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PPG | CNC |
|---|---|---|
| Founded | 1883 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paints/Coatings | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.2B | 23.2B |
| IPO Year | N/A | 2001 |
| Metric | PPG | CNC |
|---|---|---|
| Price | $112.14 | $46.14 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 17 |
| Target Price | ★ $123.67 | $41.19 |
| AVG Volume (30 Days) | 1.8M | ★ 5.4M |
| Earning Date | 01-27-2026 | 02-06-2026 |
| Dividend Yield | ★ 2.49% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.34 | N/A |
| Revenue | $15,690,000,000.00 | ★ $167,680,000,000.00 |
| Revenue This Year | $0.38 | $32.52 |
| Revenue Next Year | $2.41 | $0.25 |
| P/E Ratio | $26.24 | ★ N/A |
| Revenue Growth | 8.49 | ★ 14.57 |
| 52 Week Low | $90.24 | $25.08 |
| 52 Week High | $124.74 | $66.81 |
| Indicator | PPG | CNC |
|---|---|---|
| Relative Strength Index (RSI) | 66.49 | 64.34 |
| Support Level | $108.70 | $43.28 |
| Resistance Level | $114.52 | $47.68 |
| Average True Range (ATR) | 2.31 | 1.42 |
| MACD | 0.52 | -0.18 |
| Stochastic Oscillator | 79.00 | 66.70 |
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.